Covid-19 vaccine: Bharat Biotech’s Covaxin shows 77.8% efficacy against Covid, says Lancet

The company has manufactured and supplied 150 million doses of Covaxin, and said it will achieve an annualised capacity of one billion doses by 2021-end.

from The Financial Express https://ift.tt/3kwtFkG
https://ift.tt/eA8V8J FE Bureau